CD44, as a prognostic marker, is of great significance for clinical diagnosis and cancer treatment (52), and Neuropilin-1(NRP1) is a checkpoint target with unique implications for cancer immunology and immunotherapy (53). The gene discussed is NRP1; the disease is cancer.